World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Indian Science Publications, SOCOLAR, China, Cosmos Impact Factor, Research Bible, Fuchu, Tokyo. JAPAN, Scientific Indexing Services (SIS), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Scientific Indexing, UAE, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Indian citation Index (ICI), IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Directory of Research Journals Indexing, Scholar Article Journal Index (SAJI), International Scientific Indexing ( ISI ), Scope Database, 



S. D. Labhade* and J. S. Jagtap


The introduction of the ?Maximum Tolerable Dose? (MTD) in normal treatment protocols (and its concurrent over toxicity) made vital the burden of rest periods between cycles of treatment—a training that includes re-development of tumor cells, yet in addition development of chose clones impervious to the treatment. So as to avoid the problems caused by traditional chemotherapeutic regimens, a new modality of drug administration called ?metronomic chemotherapy? has been proposed. It refers to the chronic, equally spaced administration of (generally) low doses of various chemotherapeutic drugs without extended rest periods. The curiosity of this treatment methodology lies not just in its anti- tumor efficacy with exceptionally low adverse effect, yet additionally in a cell target switch. With plenty of experimental work, beginning with the pioneering work in the Folkman and Kerbel labs, Metronomic chemotherapy (MCT) has built its foundations. Browder and colleagues demonstrated that standard chemotherapeutic drugs such as cyclophosphamide can also be used as anti-angiogenic agents. The administration of cyclophosphamide in doses lower than the MTD, at shorter intervals and without extended rest periods, showed results better than those obtained with the MTD schedule in the treatment of two cyclophosphamide-resistant tumours, Lewis lung carcinoma and the murine mammary carcinoma cell line EMT-6.

[Full Text Article]


World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here